A news story the other day just fried me to no end. It seems Gilead Sciences, an american pharmaceutical company is licensing their hepatitis C drug, Sovaldi, to 7 Indian companies, to make it more available to 91 developing nations. The usual cost is $1000. per pill. A 12 week regimen would cost $84,000.! Gilead is also going to introduce their own product at only $300. per pill. What a great company huh? What galls me is the simple fact that milk thistle ( Silybum marianum) is probably the best natural product on earth to treat any liver problem, including all the forms of hepatitis. In the american market, a guaranteed potency product with 85 % sllymarin is only about $ 20.00 a month. Are you kidding me? Over the years we have had two of our customers taken off the liver transplant list simply by using milk thistle seed extract! We even have doctors who hand out our informational literature to their patients because they have seen the results of using milk thistle by their own patients.
The pharmaceutical industry must be responsible to its investors, so instead of looking at an alternative, which could probably be grown in the countries targeted, become a cash crop to help the developing nations, and maybe cut american health costs, the big guys will just keep gouging us and putting out press releases to make everyone think they are responsible corporations. Unbelievable...
No comments:
Post a Comment